Clinical Practice Session
AKI affects approximately 20% of hospitalized patients and is associated with worse long-term outcomes. AKI survivors frequently do not recover to baseline levels of kidney function before discharge, and approximately 10% to 30% will require outpatient dialysis treatments (AKI-D). A variety of diagnostic tools, tests, and tricks are used to prognosticate an AKI survivor’s potential for recovery and, if on dialysis, to promote liberation. This session discusses the evidence for several such assessments and the approach to their application in clinical practice.
ASN thanks the ASN AKINow Recovery/Post-AKI Workgroup and Public Awareness and Education Workgroup for assistance with this session.
Support is provided by an educational grant from 3iveLabs.